Abpro Holdings (ABPO) Free Cash Flow (2022 - 2026)
Abpro Holdings' (ABPO) quarterly Free Cash Flow came in at -$2.1 million in Q1 2026, down 38.39% YoY from -$3.4 million in Q1 2025, and down 235.48% on a QoQ basis from -$620000.0 in Q4 2025.
Abpro Holdings (ABPO) Free Cash Flow (2022 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 5 years of Free Cash Flow data on file, last reported at -$2.1 million in Q1 2026.
- Quarterly Free Cash Flow fell 38.39% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.6 million (up 14.34% YoY) and the FY2025 annual result came in at -$6.0 million, up 33.49% from the prior year.
- Free Cash Flow fell to -$2.1 million in Q1 2026, from -$620000.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$35541.0 in Q2 2022 to a low of -$5.9 million in Q4 2023.
- A 5-year average of -$1.5 million and a median of -$1.3 million in 2023 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 89.52% in 2023, down 4502.18% in 2023.
- Tracing ABPO's Free Cash Flow over 5 years: stood at -$128101.0 in 2022, then slumped by 4502.18% to -$5.9 million in 2023, then jumped by 35.29% to -$3.8 million in 2024, then surged by 83.75% to -$620000.0 in 2025, then tumbled by 235.48% to -$2.1 million in 2026.
- The last three Free Cash Flow figures came in at -$2.1 million (Q1 2026), -$620000.0 (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | -1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.08 Mn |
| Mar 31, 2026 | -2.08 Mn |
| Dec 31, 2025 | -620,000.00 |
| Dec 31, 2025 | -620,000.00 |
| Sep 30, 2025 | -2.28 Mn |
| Sep 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -1.60 Mn |
| Jun 30, 2025 | -1.60 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Dec 31, 2024 | -3.82 Mn |
| Dec 31, 2024 | -3.82 Mn |
| Sep 30, 2024 | -997,000.00 |
| Sep 30, 2024 | -997,000.00 |
| Jun 30, 2024 | -1.37 Mn |
| Jun 30, 2024 | -1.37 Mn |
| Mar 31, 2024 | -2.85 Mn |
| Mar 31, 2024 | -2.85 Mn |
| Dec 31, 2023 | -5.90 Mn |
| Dec 31, 2023 | -5.90 Mn |